Females With Overactive Bladder Symptoms, Urgency & Urge Incontinence
Conditions
Brief summary
80 female patients evaluated for sexual function after receiving Mirabegron 50 mg once daily for 6 months for treatment of overactive bladder symptoms
Detailed description
80 female patients evaluated for sexual function after receiving Mirabegron 50 mg once daily for 6 months for treatment of overactive bladder symptoms
Interventions
Mirabegron 50mg once daily for treatment of overactive bladder symptoms
Sponsors
Study design
Eligibility
Inclusion criteria
* any female with overactive bladder symptoms, urgency and urgency incontinence
Exclusion criteria
* neurologic abnormalities * Weak bladder contractility * Diabetics
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Sexual function evaluation after 6 months | 6 months | Sexual function evaluation using female sexual function index FSFI |